Orgenesis announces use of the Tissue Genesis Icellator® in a Hospital for Special Surgery clinical study for rotator cuff repair
Go back to Orgenesis announces use of the Tissue Genesis Icellator® in a Hospital for Special Surgery clinical study for rotator cuff repair| Orgenesis, Inc. NEW (NASDAQ: ORGS) | Delayed: 0.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $0.52 | |||
| Open | $0.51 | 52 Week Low | $0.24 | |||
| Day High | $0.52 | P/E | 10.00 | |||
| Day Low | $0.50 | EPS | $0.05 | |||
| Volume | 11,739 | |||||
